Prevalence of Enhanced Granular Expression of Thrombospondin Type-1 Domain-Containing 7A in the Glomeruli of Japanese Patients with Idiopathic Membranous Nephropathy

Membranous nephropathy (MN) is a leading cause of nephrotic syndrome in adults. Autoantibodies against M-type phospholipase A2 receptor (PLA2R) and thrombospondin type-1 domain-containing 7A (THSD7A), which mainly belong to the IgG4 subclass, were reported as associated antibodies for the development of MN. Although PLA2R is a major target antigen for idiopathic MN, the prevalence of MN patients seropositive for PLA2R in Japan is lower than that in other countries. In this study, we conducted immunohistochemical analysis of the presence of THSD7A and PLA2R in renal specimens of MN patients to estimate the prevalence of THSD7A/PLA2R-related idiopathic MN in Japan. Enhanced granular expression of THSD7A and PLA2R was detected in 9.1% and 52.7%, respectively, of the patients with idiopathic MN. Although none of patients with secondary MN displayed enhanced granular expression of THSD7A, 5.4% of them had enhanced granular expression of PLA2R. In conclusion, the prevalence of enhanced granular expression of THSD7A in the glomeruli of Japanese patients with idiopathic MN was higher than the prevalence of MN patients seropositive for THSD7A in USA and Europe.

[1]  Huhai Zhang,et al.  Diagnostic accuracy of PLA2R autoantibodies and glomerular staining for the differentiation of idiopathic and secondary membranous nephropathy: an updated meta-analysis , 2015, Scientific Reports.

[2]  J. Klein,et al.  Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. , 2015, The New England journal of medicine.

[3]  E. Imai,et al.  Prevalence of anti-phospholipase A2 receptor antibodies in Japanese patients with membranous nephropathy , 2014, Clinical and Experimental Nephrology.

[4]  U. Panzer,et al.  Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy. , 2014, Journal of the American Society of Nephrology : JASN.

[5]  A. Segarra-Medrano,et al.  Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy. , 2014, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

[6]  N. Valtierra,et al.  Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy. , 2014, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

[7]  V. Tesar,et al.  Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[8]  L. McWilliam,et al.  Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy. , 2013, Kidney international.

[9]  Y. Kim,et al.  Autoantibodies against Phospholipase A2 Receptor in Korean Patients with Membranous Nephropathy , 2013, PloS one.

[10]  B. Rovin,et al.  IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression , 2013, Modern Pathology.

[11]  U. Panzer,et al.  Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy. , 2012, Kidney international.

[12]  J. Wetzels,et al.  Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy. , 2012, Journal of the American Society of Nephrology : JASN.

[13]  U. Panzer,et al.  An immunofluorescence test for phospholipase-A₂-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[14]  David M. Beck,et al.  Anti-phospholipase A₂ receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[15]  D. Salant,et al.  Anti-phospholipase A2 receptor antibody in membranous nephropathy. , 2011, Journal of the American Society of Nephrology : JASN.

[16]  H. Debiec,et al.  PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy. , 2011, The New England journal of medicine.

[17]  David M. Beck,et al.  Anti-Phospholipase A2 Receptor Antibodies Correlate with Clinical Status in Idiopathic Membranous Nephropathy , 2011 .

[18]  David M. Beck,et al.  Anti-phospholipase A₂ receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[19]  克治 桑門 海外論文紹介 : M-Type Phospholipase A2 Receptor as Target Antigen in Idiopathic Membranous Nephropathy , 2010 .

[20]  H. Debiec,et al.  Antigen identification in membranous nephropathy moves toward targeted monitoring and new therapy. , 2010, Journal of the American Society of Nephrology : JASN.

[21]  David M. Beck,et al.  M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. , 2009, The New England journal of medicine.

[22]  D. Cattran Management of membranous nephropathy: when and what for treatment. , 2005, Journal of the American Society of Nephrology : JASN.

[23]  A. Komatsuda,et al.  Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[24]  A. Komatsuda,et al.  IgG subclasses in patients with membranoproliferative glomerulonephritis, membranous nephropathy, and lupus nephritis. , 1997, Kidney international.

[25]  R. Monteiro,et al.  Glomerular and serum immunoglobulin G subclasses in membranous nephropathy and anti-glomerular basement membrane nephritis. , 1988, Clinical immunology and immunopathology.

[26]  Y. Hamashima,et al.  Distribution of IgG subclasses in membranous nephropathy. , 1984, Clinical and experimental immunology.